Hereditary Papillary Renal Carcinoma Type I
Journal:
Current Molecular Medicine
Volume:
4
Page:
855-868
Author(s):
Pathirage G. Dharmawardana, Alessio Giubellino and Donald P. Bottaro
Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
567-584
Author(s):
Jeff W. M. Bulte and Dara L. Kraitchman
Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Journal:
Current Drug Metabolism
Volume:
5
Page:
463-481
Author(s):
Oliver Langer and Markus Muller
Structural Features of the Interleukin-10 Family of Cytokines
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3873-3884
Author(s):
Alexander Zdanov
Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3913-3928
Author(s):
Luc Desnoyers
Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4081-4101
Author(s):
Veronic Marie Isabelle Provencher, Ersilia Coccaro, Jonathan Jacques Lacasse and Luis Maria Schang
Herpes Simplex Virus Type 1 Amplicons and their Hybrid Virus Partners, EBV, AAV, and Retrovirus
Journal:
Current Gene Therapy
Volume:
4
Page:
385-408
Author(s):
Angelika Oehmig, Cornel Fraefel, Xandra O. Breakefield and Mathias Ackermann
Herpesvirus / Retrovirus Chimeric Vectors
Journal:
Current Gene Therapy
Volume:
4
Page:
409-416
Author(s):
Alberto L. Epstein and Roberto Manservigi
Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Journal:
Current Neurovascular Research
Volume:
1
Page:
411-420
Author(s):
Yun-Hong Ding, Xia-Dong Luan, Jie Li, Jose A. Rafols, M. Guthinkonda, Fernando G. Diaz and Yuchuan Ding
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria